2026 NSFC Joint Funds with Private Enterprises (The Second Round)

2026 NSFC Joint Funds with Private Enterprises (The Second Round)
2026年度国家自然科学基金民营企业创新发展联合基金（第二批）

June 10, 2026

The Official Announcement in Chinese

Sponsors:

National Nature Science Foundation of China (NSFC)

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Mindray Bio-Medical Electronics Co., Ltd.

Hangzhou Singclean Medical Products Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Jointown Pharmaceutical Group Co., Ltd.

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Guangzhou Wondfo Biotech Co., Ltd.

Autobio Diagnostics Co., Ltd.

About:

NSFC collaborates with relevant sectors, provincial governments and enterprises to establish the Joint Funds, supporting basic research in agreed scientific and technological fields.

During this round, NSFC and several private enterprises are jointly supporting projects in life and health areas (Application Code under H – Department of Medical Science).

Funding Scale and Period: 

Key program, each project up to RMB 2,200,000 (direct costs) over 4 years.

Funding Areas and Topics:

The research areas and funding topics vary across the different industry-sponsored Joint Funds. Please refer to the official announcement for the specific priorities of each fund.

Eligibility:

• Applicant should have experience to conduct basic research and hold a senior professional title (Tenure-track Assistant Prof. or above).
• Applicant can only apply for one program under “joint funds with private enterprises”.
• Joint Funds with private enterprises are NOT counted towards the “two-project” limit at the time of application. Once the application is accepted and routed for review, it will be counted towards the “two-project” limit.

For further details on applicant eligibility, please refer to the respective program guide and the 2026 NSFC Program Guide.

Important Dates: